Drug General Information |
Drug ID |
D0OH2P
|
Former ID |
DIB018097
|
Drug Name |
(S)-(+)-CBPG
|
Drug Type |
Small molecular drug
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Structure |
|
Download
2D MOL
|
Formula |
C8H11NO4
|
InChI |
InChI=1S/C8H11NO4/c9-4(5(10)11)7-1-8(2-7,3-7)6(12)13/h4H,1-3,9H2,(H,10,11)(H,12,13)/t4-,7?,8?/m1/s1
|
InChIKey |
KNSHLWJBSDBBRH-XOJFDHPMSA-N
|
PubChem Compound ID |
|
PubChem Substance ID |
7978869, 11056226, 15120700, 15586690, 39340769, 52693785, 57359334, 103216813, 103949151, 114155115, 117518367, 128408754, 131400561, 163058346, 178100427, 180666391, 227531750, 252356524
|
Target and Pathway |
Target(s) |
Metabotropic glutamate receptor 5 |
Target Info |
Agonist |
[2]
|
Metabotropicglutamate receptor 1 |
Target Info |
Antagonist |
[2]
|
KEGG Pathway
|
Calcium signaling pathway
|
Neuroactive ligand-receptor interaction
|
Gap junction
|
Long-term potentiation
|
Retrograde endocannabinoid signaling
|
Glutamatergic synapse
|
Huntington's diseasehsa04020:Calcium signaling pathway
|
FoxO signaling pathway
|
Long-term depression
|
Estrogen signaling pathway
|
PANTHER Pathway
|
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
|
Metabotropic glutamate receptor group III pathway
|
Metabotropic glutamate receptor group I pathway
|
Endogenous cannabinoid signalingP00027:Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
|
Endogenous cannabinoid signaling
|
Reactome
|
G alpha (q) signalling events
|
Class C/3 (Metabotropic glutamate/pheromone receptors)R-HSA-416476:G alpha (q) signalling events
|
Class C/3 (Metabotropic glutamate/pheromone receptors)
|
WikiPathways
|
Hypothetical Network for Drug Addiction
|
GPCRs, Class C Metabotropic glutamate, pheromone
|
Gastrin-CREB signalling pathway via PKC and MAPK
|
GPCR ligand binding
|
GPCR downstream signalingWP666:Hypothetical Network for Drug Addiction
|
GPCR downstream signaling
|
GPCRs, Other
|
References |
REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3421). |
---|
REF 2 | Biochemical and electrophysiological studies on (S)-(+)-2-(3'-carboxybicyclo(1.1.1)pentyl)-glycine (CBPG), a novel mGlu5 receptor agonist endowed with mGlu1 receptor antagonist activity. Neuropharmacology. 1999 Jul;38(7):917-26. |